Cargando…
Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation
Autores principales: | Han, Mingli, Gu, Yuanting, Lu, Pengwei, Li, Jingyi, Cao, Hui, Li, Xiangke, Qian, Xueke, Yu, Chao, Yang, Yunqing, Yang, Xue, Han, Na, Dou, Dongwei, Hu, Jianguo, Dong, Huaying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275128/ https://www.ncbi.nlm.nih.gov/pubmed/35820907 http://dx.doi.org/10.1186/s12943-022-01610-z |
Ejemplares similares
-
Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation
por: Han, Mingli, et al.
Publicado: (2020) -
Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer
por: Han, Mingli, et al.
Publicado: (2020) -
Retraction Note: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer
por: Han, Mingli, et al.
Publicado: (2023) -
LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic role in retinoblastoma
por: Hao, Fengqin, et al.
Publicado: (2018) -
LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells
por: Shi, Xiuhui, et al.
Publicado: (2017)